Cargando…

Sarcoid Uveitis: An Intriguing Challenger

The purpose of our work is to describe the actual knowledge concerning etiopathogenesis, clinical manifestations, diagnostic procedures, complications and therapy of ocular sarcoidosis (OS). The study is based on a recent literature review and on the experience of our tertiary referral center. Data...

Descripción completa

Detalles Bibliográficos
Autores principales: Allegri, Pia, Olivari, Sara, Rissotto, Federico, Rissotto, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316395/
https://www.ncbi.nlm.nih.gov/pubmed/35888617
http://dx.doi.org/10.3390/medicina58070898
_version_ 1784754802208538624
author Allegri, Pia
Olivari, Sara
Rissotto, Federico
Rissotto, Roberta
author_facet Allegri, Pia
Olivari, Sara
Rissotto, Federico
Rissotto, Roberta
author_sort Allegri, Pia
collection PubMed
description The purpose of our work is to describe the actual knowledge concerning etiopathogenesis, clinical manifestations, diagnostic procedures, complications and therapy of ocular sarcoidosis (OS). The study is based on a recent literature review and on the experience of our tertiary referral center. Data were retrospectively analyzed from the electronic medical records of 235 patients (461 eyes) suffering from a biopsy-proven ocular sarcoidosis. Middle-aged females presenting bilateral ocular involvement are mainly affected; eye involvement at onset is present in one-third of subjects. Uveitis subtype presentation ranges widely among different studies: panuveitis and multiple chorioretinal granulomas, retinal segmental vasculitis, intermediate uveitis and vitreitis, anterior uveitis with granulomatous mutton-fat keratic precipitates, iris nodules, and synechiae are the main ocular features. The most important complications are cataract, glaucoma, cystoid macular edema (CME), and epiretinal membrane. Therapy is based on the disease localization and the severity of systemic or ocular involvement. Local, intravitreal, or systemic steroids are the mainstay of treatment; refractory or partially responsive disease has to be treated with conventional and biologic immunosuppressants. In conclusion, we summarize the current knowledge and assessment of ophthalmological inflammatory manifestations (mainly uveitis) of OS, which permit an early diagnostic assay and a prompt treatment.
format Online
Article
Text
id pubmed-9316395
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93163952022-07-27 Sarcoid Uveitis: An Intriguing Challenger Allegri, Pia Olivari, Sara Rissotto, Federico Rissotto, Roberta Medicina (Kaunas) Review The purpose of our work is to describe the actual knowledge concerning etiopathogenesis, clinical manifestations, diagnostic procedures, complications and therapy of ocular sarcoidosis (OS). The study is based on a recent literature review and on the experience of our tertiary referral center. Data were retrospectively analyzed from the electronic medical records of 235 patients (461 eyes) suffering from a biopsy-proven ocular sarcoidosis. Middle-aged females presenting bilateral ocular involvement are mainly affected; eye involvement at onset is present in one-third of subjects. Uveitis subtype presentation ranges widely among different studies: panuveitis and multiple chorioretinal granulomas, retinal segmental vasculitis, intermediate uveitis and vitreitis, anterior uveitis with granulomatous mutton-fat keratic precipitates, iris nodules, and synechiae are the main ocular features. The most important complications are cataract, glaucoma, cystoid macular edema (CME), and epiretinal membrane. Therapy is based on the disease localization and the severity of systemic or ocular involvement. Local, intravitreal, or systemic steroids are the mainstay of treatment; refractory or partially responsive disease has to be treated with conventional and biologic immunosuppressants. In conclusion, we summarize the current knowledge and assessment of ophthalmological inflammatory manifestations (mainly uveitis) of OS, which permit an early diagnostic assay and a prompt treatment. MDPI 2022-07-04 /pmc/articles/PMC9316395/ /pubmed/35888617 http://dx.doi.org/10.3390/medicina58070898 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Allegri, Pia
Olivari, Sara
Rissotto, Federico
Rissotto, Roberta
Sarcoid Uveitis: An Intriguing Challenger
title Sarcoid Uveitis: An Intriguing Challenger
title_full Sarcoid Uveitis: An Intriguing Challenger
title_fullStr Sarcoid Uveitis: An Intriguing Challenger
title_full_unstemmed Sarcoid Uveitis: An Intriguing Challenger
title_short Sarcoid Uveitis: An Intriguing Challenger
title_sort sarcoid uveitis: an intriguing challenger
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316395/
https://www.ncbi.nlm.nih.gov/pubmed/35888617
http://dx.doi.org/10.3390/medicina58070898
work_keys_str_mv AT allegripia sarcoiduveitisanintriguingchallenger
AT olivarisara sarcoiduveitisanintriguingchallenger
AT rissottofederico sarcoiduveitisanintriguingchallenger
AT rissottoroberta sarcoiduveitisanintriguingchallenger